EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $158,000 | -61.9% | 25,000 | -50.0% | 0.08% | -58.3% |
Q1 2022 | $415,000 | -40.8% | 50,000 | -63.0% | 0.20% | -41.2% |
Q4 2021 | $701,000 | -22.3% | 135,000 | 0.0% | 0.35% | -26.9% |
Q3 2021 | $902,000 | -21.6% | 135,000 | 0.0% | 0.48% | -31.5% |
Q2 2021 | $1,150,000 | -7.2% | 135,000 | -3.6% | 0.69% | -10.0% |
Q1 2021 | $1,239,000 | -22.5% | 140,000 | +7.7% | 0.77% | -32.5% |
Q4 2020 | $1,598,000 | +63.6% | 130,000 | +8.3% | 1.14% | +52.1% |
Q3 2020 | $977,000 | +31.3% | 120,000 | +54.8% | 0.75% | +30.7% |
Q2 2020 | $744,000 | – | 77,500 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |